 |
|
Diabetes research yielding breakthrough success
March 17, 2006University of Calgary bioengineering team successfully growing insulin-producing cells in lab
Freedom from insulin injections and the myriad of health problems related to type 1 diabetes is closer to becoming reality, thanks to University of Calgary researchers who are developing the first bioreactor procedures to grow pancreatic cells in their laboratory. This opens the door to the possibility of providing a steady supply of insulin-producing cells that can be transplanted into patients affected by this serious disease.
"This is a significant milestone on the path to effectively producing human tissue that may be used to treat type 1 diabetes," said Dr. Leo Behie, professor of chemical engineering in the Schulich School of Engineering and holder of a Canada Research Chair in BioMedical Engineering. "The precursor cell type we are using appears to be a good candidate and brings us much closer to clinical trials," Behie said. "There is a huge international push to find a human pancreatic cell source- a 'holy grail' of sorts- that could be used for transplantation. Once it is found, our lab will be ready to grow these cells in a clinically acceptable manner."
In a study funded by the New York-based Juvenile Diabetes Research Foundation (JDRF) to appear shortly in the journal Biotechnology Progress, Behie's team developed bioreactor protocols to produce large quantities of pig pancreatic insulin-producing cells that has set the stage for the large-scale production of islet-like structures containing insulin-producing cells. This work was conducted at the Pharmaceutical Production Research Facility (PPRF) and included U of C colleagues Meera Chawla, Cheryl Bodnar, Michael Kallos and Arindom Sen.
In a second paper available online for the journal Biotechnology and Bioengineering, Behie and colleagues report that they have cultured human cells that are believed to be good candidates for generating islet cells that can make insulin. The study sponsored, by the Canadian Stem Cell Network, included Cheryl Bodnar, Michael Kallos and Arindom Sen, in collaboration with Maria Petropavlovskaia and Lawrence Rosenberg from McGill University's Faculty of Medicine. The successful growth and characterization of these functional islet cells in the lab led to the conclusion that they may be suitable for treating individuals with type 1 diabetes, formerly known as juvenile diabetes, which requires patients to receive multiple daily insulin injections in order to survive.
"This is very encouraging news for people with type 1 diabetes who look forward to a future without this serious condition," said Donna Lillie, Vice President, Research and Professional Education, Canadian Diabetes Association. "Dr. Behie's all-Canadian team has brought us one more step towards potentially securing a large supply of insulin-producing pancreatic cells for transplantation into individuals with type 1 diabetes."
Scientists at the University of Alberta were the first to successfully transplant islet cells into people with diabetes in 2000, freeing them from insulin injections. Follow-up studies have shown that the transplanted cells continued to function in many of these so-called Edmonton Protocol patients for up to five years. However, a significant bottleneck to treating large numbers of people with type 1 diabetes using this approach is that it takes pancreas cells from as many as three donor cadavers to supply enough for one patient transplant.
"Injecting islet cells into people with diabetes has gotten people off insulin. The problem is there aren't enough cells available to treat everyone," Behie said. "If we can expand cell populations in our bioreactors, we'll be able to supply everyone who needs them and dramatically improve their quality of life."
About 10 per cent of Edmonton Protocol transplant recipients have been able to stay off insulin after five years, and patients are required to take anti-rejection drugs after receiving the new cells. By producing a reliable supply of cells, Behie said he hopes people with type 1 diabetes will one day be able to receive booster shots of islet cells, as required, and that producing cloned cells from individual patients could result in the elimination of transplant rejection issues.
Behie is the only Canadian member of a "dream team" of researchers established by the New York-based Juvenile Diabetes Research Foundation International (JDRF) last year in hopes of accelerating the development of new therapies and possible cures for type 1 diabetes. The 16 researchers from 13 universities around the world are trying to uncover the cause of type 1 diabetes that affects more than 19-million people worldwide, and investigating various potential cures including new drug therapies and islet cell regeneration techniques. Type 1 diabetes affects about 19 million people worldwide, while type 1 and 2 diabetes affects approximately 194 million.
University of Calgary
In a second paper available online for the journal Biotechnology and Bioengineering, Behie and colleagues report that they have cultured human cells that are believed to be good candidates for generating islet cells that can make insulin. The study sponsored, by the Canadian Stem Cell Network, included Cheryl Bodnar, Michael Kallos and Arindom Sen, in collaboration with Maria Petropavlovskaia and Lawrence Rosenberg from McGill University's Faculty of Medicine. The successful growth and characterization of these functional islet cells in the lab led to the conclusion that they may be suitable for treating individuals with type 1 diabetes, formerly known as juvenile diabetes, which requires patients to receive multiple daily insulin injections in order to survive.
"This is very encouraging news for people with type 1 diabetes who look forward to a future without this serious condition," said Donna Lillie, Vice President, Research and Professional Education, Canadian Diabetes Association. "Dr. Behie's all-Canadian team has brought us one more step towards potentially securing a large supply of insulin-producing pancreatic cells for transplantation into individuals with type 1 diabetes."
Scientists at the University of Alberta were the first to successfully transplant islet cells into people with diabetes in 2000, freeing them from insulin injections. Follow-up studies have shown that the transplanted cells continued to function in many of these so-called Edmonton Protocol patients for up to five years. However, a significant bottleneck to treating large numbers of people with type 1 diabetes using this approach is that it takes pancreas cells from as many as three donor cadavers to supply enough for one patient transplant.
"Injecting islet cells into people with diabetes has gotten people off insulin. The problem is there aren't enough cells available to treat everyone," Behie said. "If we can expand cell populations in our bioreactors, we'll be able to supply everyone who needs them and dramatically improve their quality of life."
About 10 per cent of Edmonton Protocol transplant recipients have been able to stay off insulin after five years, and patients are required to take anti-rejection drugs after receiving the new cells. By producing a reliable supply of cells, Behie said he hopes people with type 1 diabetes will one day be able to receive booster shots of islet cells, as required, and that producing cloned cells from individual patients could result in the elimination of transplant rejection issues.
Behie is the only Canadian member of a "dream team" of researchers established by the New York-based Juvenile Diabetes Research Foundation International (JDRF) last year in hopes of accelerating the development of new therapies and possible cures for type 1 diabetes. The 16 researchers from 13 universities around the world are trying to uncover the cause of type 1 diabetes that affects more than 19-million people worldwide, and investigating various potential cures including new drug therapies and islet cell regeneration techniques. Type 1 diabetes affects about 19 million people worldwide, while type 1 and 2 diabetes affects approximately 194 million.
University of Calgary
Type 1 Diabetes Current Events and Type 1 Diabetes News RSSUM Scientists Create Fruit Fly Model to Help Unravel Genetics of Human Diabetes
As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis.
Vegetables can protect unborn child against diabetes
New evidence is emerging for how important it is for pregnant women to eat good, nutritious food. Expecting mothers who eat vegetables every day seem to have children who are less likely to develop type 1 diabetes, a new study from the Sahlgrenska Academy has revealed.
Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.
Diabetic Episodes Affect Kids' Memory
Children who have had an episode of diabetic ketoacidosis, a common complication of diabetes, may have persistent memory problems, according to a new study from researchers at the UC Davis Center for Mind and Brain.
A major step in making better stem cells from adult tissue
October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells.
Blood counts are clues to human disease
A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have on common human diseases.
Self-monitoring of blood glucose
Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment.
Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market.
Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award.
JDRF-funded studies show regular CGM use increases diabetes control for all age groups
The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.
More Type 1 Diabetes Current Events and Type 1 Diabetes News Articles
 |
Type 1 Diabetes For Dummies (For Dummies (Health & Fitness)) by Alan L. Rubin MD (Author) Whether you have been living with type 1 diabetes for some time, or you have just discovered that your child is diabetic, there’s a lot you need to know about the new developments in treating, controlling, and living with this disease. Type 1 Diabetes For Dummies, explains everything you need to know and do to make living with type 1 diabetes easier and healthier. This reassuring, plain-English guide helps you understand and mange the disease with tips on working with your doctor, administering insulin, developing a diet an exercise plan, and coping with illness and travel. You’ll find out about the latest technologies of blood glucose monitoring and insulin delivery, and get a handle on everything you need to do to keep yourself or your child healthy, active, and feeling... |
 |
Type 1 Diabetes: A Guide for Children, Adolescents, Young Adults--and Their Caregivers, Third Edition by M.D. Ragnar Hanas M.D. (Author), Ph.D. Stuart Brink Ph.D. (Foreword), Jeff Hitchcock (Foreword) Living with type 1 diabetes requires intensive, nonstop daily management, week after week, year after year. This means that young people with type 1 and their parents have to become experts on their own condition—even better informed than the average doctor—and able to self-manage its daily demands. The Type 1 Diabetes Book is the most authoritative book ever published on the condition and will become the one book that every young person with type 1 diabetes will need to own. "In this book," writes author Dr. Ragnar Hanas, "I speak directly, all the time, to you, the person with diabetes. The topics covered range from how your body works to sweets, treats, and ice cream; from insulin injection technique to long-term complications; and any number of subjects in between. With this book... |
 |
Medical Management of Type 1 Diabetes by American Diabetes Association (ADA) (Author) Featuring a recommended course of diagnosing and treating patients with type 1 diabetes A comprehensive resource for health care professionals that outlines the American Diabetes Association’s recommended course of diagnosing and treating patients with type 1 diabetes. This comprehensive volume provides the basis for individualized, flexible, responsive treatment plans for patients with type 1 diabetes. It includes integrated approaches on blood pressure and lipid goals, proper nutrition, exercise, smoking cessation, and more. All based on the clinical practice recommendations of the American Diabetes Association. |
 |
A Field Guide to Type 1 Diabetes by American Diabetes Association (Author) Living with diabetes is as challenging as hiking and camping in the wilderness. As it always pays to be prepared before beginning a journey, it also pays for people with diabetes to be prepared before they start each day. In true Field Guide fashion, this book boils down vital information for readers into short sections and checklists of their necessities, what they need to do, and what to take with them on the course of their day. A Field Guide to Type 1 Diabetes includes sections on insulin; tools, food, and exercise; complications; and how to's. Key features include: Background on the biology and physical aspects of type 1 diabetes Vital information about insulin, insulin plans, and delivery methods Easy-to-understand charts and checklists that walk readers through... |
 |
Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin (Marlowe Diabetes Library) by Gabrielle Kaplan-Mayer (Author), M.S. Gary Scheiner M.S. (Foreword) Increasing numbers of people with type 1 diabetes, all of whose lives depend on insulin, as well as type 2 diabetics, have already adopted the insulin pump, which replaces a regimen of insulin shots with a continuous delivery of insulin. Yet many who stand to benefit from "the pump" are put off by not fully understanding the device, and many already using it don’t have anyone with whom to compare notes about its use. Now Gabrielle Kaplan-Mayer, who has used the pump for more than three years, cuts through common personal fears about the pump and offers insight into the day-to-day challenges—and rewards—of life with it. Drawing on interviews with more than seventy-five pump users, including Nicole Johnson, Miss America 1999, as well as diabetes experts and other health professionals,... |
 |
Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin by M.S. Gary Scheiner M.S. (Author), Ph.D. Barry Goldstein M.D. M.D. (Foreword) Dozens of books offer advice on managing diabetes, but few focus specifically on the day-to-day issues facing those who use insulin. Now Gary Scheiner, a certified diabetes educator and himself an insulin user himself since 1985, gives you the tools to "think like a pancreas"--that is, to successfully master the art and science of matching insulin to the body’s ever-changing needs. Free of medical mumbo jumbo, comprehensive, and packed with useful information not readily available in other books, Think Like a Pancreas discusses: • day-to-day blood glucose control and monitoring |
 |
Ampalaya: Nature's Remedy for Type 1 And Type 2 Diabetes by Frank Murray (Author) Diabetes mellitus--the fifth leading cause of death in the United States--increased alarmingly in 1999, prompting the government to call the disease an unfolding epidemic. By 2025,it is estimated there will be 22 million Americans with diabetes. As this book details, diabetes can often be prevented or controlled with positive lifestyle changes, including the use of ampalaya (aka bitter melon), a vegetable that is being used around the world as a tea, in capsules, or in its whole form to successfully lower blood sugar levels in diabetics. The vegetable itself is also tasty and beneficial. This book will teach you everything you need to know to put ampalaya to work for you. |
 |
No Added Sugar - growing up with type 1 diabetes by Fibi Ward (Author) Fibi Ward, now 14, writes: 'At the time I was diagnosed [aged 13], I wanted to read something written by somebody of my own age, from their perspective, about how they dealt with being diagnosed, and to reassure myself that all the fears and worries that I had were normal. However,I have not seen any such book on the market and have decided to record my own experiences so that other children and teenagers who are newly diagnosed with type 1 diabetes can get some benefit and comfort by reading about and relating to them.' According to Diabetes UK, 10,000 to 15,000 people in the UK are diagnosed with type 1 diabetes every year. The peak age of diagnosis is between 10 and 14 years. Coming so early in life, such a diagnosis can feel like a life sentence, both for the young person and for... |
 |
Appraise Hemoglobin A1C Home Test Kit by Appraise INDICATIONS: Appraise diabetes A1c home test kit, 90462. Clinically accurate information you can use with your Healthcare provider to assess your daibetes treatment plan. |
 |
WeeklyTrack Diabetes Management Kit (The Complete Diabetes Self-Management Log Book) by OSS Publishing Company (Author) Improve your diabetes self-management! This easy-to-use diabetes log book covers all aspects of diabetes self-care for Type 1 or Type 2 diabetics, whether using oral medications (pills), insulin injections, or an insulin pump. No more chasing separate pieces of paper and fumbling with tiny booklets!WeeklyTrack Diabetes Management Kit keeps all of your detailed diabetes information in one book, but still shows you the "big picture" of your diabetes management. Each WeeklyTrack book holds one full year of information. Unlike other systems, there are no refills or extras to buy. One book per year is all you need. It's not a calendar -- start when you want, fill in your own dates. Designed by a diabetic, WeeklyTrack provides daily diabetes logging with color-coded charts in a unique... |
| © 2009 BrightSurf.com |